Rapid development of pulmonary Mycobacterium avium infection during chemoradiotherapy followed by durvalumab treatment in a locally advanced NSCLC patient

• DOI: 10.1016/j.lungcan.2021.01.021
• Publication Date: 2021-01-30T16:02:25Z
• Authors: Keisuke Baba; Tatsuya Yoshida; Mika Shiotsuka; Osamu Kobayashi; Satoshi Iwata; Yuichiro Ohe
• Keywords: 0301 basic medicine; 03 medical and health sciences; Lung Neoplasms; SDG 3 - Good Health and Well-being; EMC OR-01; Antibodies, Monoclonal; Humans; Chemoradiotherapy; Mycobacterium avium